Skip to main content
Atrás
PRCT logo

PROCEPT BioRobotics Corporation

Calidad de datos: 100%
PRCT
NASDAQ Healthcare Medical - Devices
$24.94
▼ $0.16 (-0.64%)
Cap. Mercado: 1.41B
Rango del Día
$24.64 $25.90
Rango de 52 Semanas
$19.35 $66.85
Volumen
918,360
Promedio 50D / 200D
$28.17 / $38.37
Cierre Anterior
$25.10

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E -14.7 0.3
P/B 3.8 3.0
ROE % -24.9 3.7
Net Margin % -31.0 3.8
Rev Growth 5Y % 72.9 10.0
D/E 0.1 0.2

Precio Objetivo de Analistas

Hold
$47.00 +88.5%
Low: $30.00 High: $62.00
EPS Futuro
-$1.53
Ingresos Est.
397.51M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $0.41
$0.38 – $0.43
 737.18M 5
FY2029 -$0.33
-$0.35 – -$0.30
 661.43M 2
FY2028 -$0.34
-$1.22 – $1.43
 585.62M 7

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-25 -$0.32 -$0.53 -63.6%
2025-11-04 -$0.41 -$0.38 +7.3%
2025-08-06 -$0.41 -$0.35 +14.6%
2025-04-24 -$0.49 -$0.45 +8.2%
2025-02-25 -$0.34 -$0.35 -2.9%
2024-10-28 -$0.48 -$0.40 +16.7%
2024-08-01 -$0.52 -$0.50 +3.8%
2024-05-01 -$0.55 -$0.51 +7.3%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 72.90% annually over 5 years — strong growth
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -58.34M
Revenue growth is decelerating — 1Y growth trails 5Y average by 35.68%
Capital efficient — spends only 3.04% of revenue on capex

Crecimiento

Revenue Growth (5Y)
72.90%
Revenue (1Y)37.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-24.89%
ROIC-18.66%
Net Margin-31.02%
Op. Margin-33.71%

Seguridad

Debt / Equity
0.14
Current Ratio6.85
Interest Coverage-11.69

Valoración

P/E Ratio
-14.72
Forward P/EN/A
P/B Ratio3.84
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 37.22% Revenue Growth (3Y) 50.40%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 72.90% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 308.05M Net Income (TTM) -95.57M
ROE -24.89% ROA -18.81%
Gross Margin 63.70% Operating Margin -33.71%
Net Margin -31.02% Free Cash Flow (TTM) -58.34M
ROIC -18.66% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.14 Current Ratio 6.85
Interest Coverage -11.69
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -14.72 Forward P/E N/A
P/B Ratio 3.84 P/S Ratio 4.57
PEG Ratio 10.70 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA 6.19
Forward P/S 3.54 Fwd Earnings Yield N/A
FCF Yield -4.15%
Market Cap 1.41B Enterprise Value 1.17B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 308.05M 224.50M 136.19M 75.01M 34.47M
Net Income -95.57M -91.41M -105.90M -87.15M -59.85M
EPS (Diluted) -1.72 -1.75 -2.24 -1.96 -1.37
Gross Profit 196.23M 137.10M 71.05M 37.09M 15.87M
Operating Income -103.86M -96.61M -109.17M -80.72M -54.16M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 508.08M 534.02M 404.72M 309.33M 337.02M
Total Liabilities 142.21M 131.80M 123.97M 112.26M 69.93M
Shareholders' Equity 365.87M 402.22M 280.75M 197.07M 267.09M
Total Debt 51.62M 80.25M 79.20M 77.32M 54.10M
Cash & Equivalents 286.50M 333.73M 257.22M 222.64M 304.32M
Current Assets 450.38M 481.84M 350.57M 272.63M 326.17M
Current Liabilities 65.80M 53.13M 45.93M 35.29M 16.24M